Bank of America
MRNA icon

Bank of America’s Moderna MRNA Stock Holding History

Bank of America’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-50,000
Closed -$2.08M – 8445
2024
Q4 		$2.08M Buy
+50,000
New +$2.39M ﹤0.01% 4407
2024
Q3 		– Sell
-161,140
Closed -$19.1M – 8324
2024
Q2 		$19.1M Sell
161,140
-17,160
-10% -$2.17M ﹤0.01% 2298
2024
Q1 		$19M Buy
178,300
+157,900
+774% +$15.9M ﹤0.01% 2341
2023
Q4 		$2.03M Sell
20,400
-55,300
-73% -$4.65M ﹤0.01% 4397
2023
Q3 		$7.82M Buy
75,700
+54,800
+262% +$6.11M ﹤0.01% 2976
2023
Q2 		$2.54M Sell
20,900
-509,800
-96% -$68M ﹤0.01% 4001
2023
Q1 		$81.5M Sell
530,700
-337,800
-39% -$55.7M 0.01% 1053
2022
Q4 		$156M Buy
868,500
+18,000
+2% +$2.94M 0.02% 698
2022
Q3 		$101M Buy
850,500
+804,400
+1,745% +$122M 0.01% 849
2022
Q2 		$6.59M Sell
46,100
-719,000
-94% -$103M ﹤0.01% 3099
2022
Q1 		$132M Buy
765,100
+29,600
+4% +$4.98M 0.01% 821
2021
Q4 		$187M Sell
735,500
-830,800
-53% -$243M 0.02% 696
2021
Q3 		$603M Sell
1,566,300
-381,300
-20% -$141M 0.06% 298
2021
Q2 		$458M Buy
1,947,600
+1,589,800
+444% +$284M 0.05% 365
2021
Q1 		$46.9M Buy
357,800
+303,500
+559% +$44M 0.01% 1344
2020
Q4 		$5.67M Buy
54,300
+30,200
+125% +$3.06M ﹤0.01% 3014
2020
Q3 		$1.71M Buy
24,100
+200
+0.8% +$13.9K ﹤0.01% 3806
2020
Q2 		$1.53M Buy
23,900
+23,500
+5,875% +$1.29M ﹤0.01% 3806
2020
Q1 		$12K Buy
+400
New +$9.2K ﹤0.01% 6309

Other funds holding MRNA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America's MRNA Position: Q1 2026 in Review

Bank of America reduced its Moderna (MRNA) stake by 28% in Q1 2026, selling an estimated $18.1M and leaving 986,360 shares worth $50.1M. The position accounts for ﹤0.01% of the portfolio, ranked #1592.

Bank of America first reported a position in MRNA in Q4 2018 and has held it in 30 quarters since. The position peaked at $308M in Q3 2021. 723 funds tracked by Wall St. Rank hold MRNA as of Q1 2026.

  • Bank of America held 986,360 shares of Moderna worth $50.1M as of Q1 2026.
  • Bank of America sold 388,494 Moderna shares in Q1 2026, an estimated $18.1M.
  • Moderna made up ﹤0.01% of Bank of America's portfolio in Q1 2026, its #1592 holding.
  • Bank of America first reported a position in Moderna in Q4 2018 and has held it in 30 quarters since.
  • Bank of America's Moderna position peaked at $308M in Q3 2021.
  • 723 funds tracked by Wall St. Rank held Moderna as of Q1 2026.

Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.